Spyre Therapeutics, Inc. (SYRE)

73.01 +3.31 (+4.75%) USD  |  NASDAQ  |  Apr 17, 16:00
74.59 +1.58 (+2.16%) Pre-Market: 20:00
More

Spyre Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Tyra Biosciences, Inc. --
Replimune Group, Inc. --
Savara, Inc. --
Regeneron Pharmaceuticals, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade